SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-048448
Filing Date
2021-07-28
Accepted
2021-07-28 17:24:44
Documents
1
Period of Report
2019-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9220
  Complete submission text file 0001209191-21-048448.txt   11053
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Issuer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488
Business Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488 82-31-628-3200
Genexine Inc. (Reporting) CIK: 0001834377 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39683 | Film No.: 211123794